Pharma And Biotech CRM Software Market Report 2026

Pharma And Biotech CRM Software Market Overview

• Pharma And Biotech CRM Software market size has reached to $4.72 billion in 2025 • Expected to grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Impact Of Personalized Medicine On The Pharma And Biotech CRM Software Market • Market Trend: Revolutionizing Pharma And Biotech CRM With AI-Powered Personalized Engagement • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharma And Biotech CRM Software Market?

Pharma and biotech CRM software is a specialized tool designed to assist pharmaceutical and biotech companies in managing customer relationships, data, and interactions effectively. This software helps organizations offer a seamless and unique customer experience, enabling them to build better relationships by providing a complete picture of customer interactions. The main technology types of pharma and biotech CRM software are artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). AI-driven pharma and biotech CRM software utilizes artificial intelligence and machine learning algorithms to analyze customer data, provide insights, and automate tasks. The deployment types include on-premises and cloud-based in large enterprises, small and medium enterprises (SMEs) within pharmaceuticals, and biotech industries.

What Is The Pharma And Biotech CRM Software Market Growth Forecast?

The pharma and biotech crm software market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing investments in ai-powered crm platforms, rising demand for real-time customer insights, expansion of cloud adoption among pharma companies, growing focus on data-driven decision-making, increasing integration with advanced analytics platforms. Major trends in the forecast period include increasing adoption of AI-driven sales analytics, growing use of personalized engagement platforms, expansion of cloud-based crm deployments, rising focus on omnichannel customer interaction, integration of advanced compliance and data security features.

Global Pharma And Biotech CRM Software Market Segmentation

1) By Technology: Artificial Intelligence Customer Relationship Management (CRM), Conventional Customer Relationship Management (CRM) 2) By Deployment: On-Premises, Cloud Based 3) By Enterprise Size: Large Enterprise, Small And Medium Enterprise (SMEs) 4) By Industry: Pharmaceuticals, Biotech Subsegments: 1) By Artificial Intelligence Customer Relationship Management (CRM): AI-Powered Sales Automation, AI-Driven Customer Insights And Analytics, Predictive Analytics For Lead Scoring, Chatbots And Virtual Assistants, Natural Language Processing (NLP) For Customer Interaction, Personalized Marketing And Campaign Management, Sentiment Analysis And Customer Feedback Analysis, Machine Learning For Sales Forecasting 2) By Conventional Customer Relationship Management (CRM): Contact And Lead Management, Sales Pipeline And Opportunity Management, Marketing Automation And Campaign Management, Customer Service And Support Modules, Email Marketing And Communication Tools, Customer Segmentation And Targeting, Activity Tracking And Reporting, Integration With ERP And Other Business Systems

What Is The Driver Of The Pharma And Biotech CRM Software Market?

The growing need for personalized medicine is expected to propel the growth of the pharma and biotech CRM software market going forward. Personalized medicine is a medical approach that customizes healthcare decisions and treatments for individual patients based on their genetic makeup, environmental factors, and lifestyle. The growing demand for personalized medicines is driven by higher rates of cancer and the increasing incidence of chronic diseases among the population. The demand for customized medicine necessitates using pharma and biotech CRM software to manage patient data, track treatment outcomes, and facilitate personalized healthcare delivery efficiently. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit advocacy organization, reported that in 2023 the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the growing demand for personalized medicine is driving the growth of the pharma and biotech CRM software industry.

Key Players In The Global Pharma And Biotech CRM Software Market

Major companies operating in the pharma and biotech crm software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd., Pegasystems Inc., Microsoft Dynamics 365

Global Pharma And Biotech CRM Software Market Trends and Insights

Major companies operating in the pharma and biotech CRM software market are increasingly incorporating artificial intelligence (AI) and machine learning capabilities into platforms such as the AI-powered personalized engagement platform to meet the growing demand for advanced customer relationship management tools tailored to the pharmaceutical and biotechnology industries. AI-powered personalized engagement enables companies to deliver targeted and relevant messaging to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a US-based provider of cloud-based software solutions, launched its new life sciences cloud to streamline patient engagement and clinical operations with data, automation, and trusted AI. It enables pharmaceutical and medical technology organizations to streamline patient engagement, clinical operations, commercial lifecycle management, and personalized stakeholder experiences across the drug and device development journey.

What Are Latest Mergers And Acquisitions In The Pharma And Biotech CRM Software Market?

In January 2024, Nomadia, a France-based provider of cloud-based SaaS solutions, acquired Nomadvantage for an undisclosed amount. This acquisition strategically aligns with its goal of expanding its cloud-based SaaS solutions portfolio and enhancing its market presence. Nomadvantage is a France-based customer relations management software provider specializing in the healthcare and pharmaceutical industries.

Regional Outlook

North America was the largest region in the pharma and biotech CRM software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharma And Biotech CRM Software Market?

The pharma and biotech CRM software market consists of revenues earned by entities through services such as customer relationship management, sales force automation, marketing automation, mobile and remote access, and integration with the healthcare ecosystem. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma and biotech CRM market also includes sales of lead management software, email marketing software, call center software, event management software, and training and education software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharma And Biotech CRM Software Market Report 2026?

The pharma and biotech crm software market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharma and biotech crm software industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.